{"id":"W4283328977","doi":"10.1097/01.hs9.0000845556.79615.3f","title":"P668: ACALABRUTINIB VS RITUXIMAB PLUS IDELALISIB OR BENDAMUSTINE IN RELAPSED/REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA: ASCEND RESULTS AT ~4 YEARS OF FOLLOW-UP","year":2022,"lang":"en","type":"article","venue":"HemaSphere","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"Saint John Regional Hospital; University of New Brunswick","funders":"","keywords":"Bendamustine; Medicine; Idelalisib; Internal medicine; Chronic lymphocytic leukemia; Gastroenterology; Tolerability; Rituximab; Progression-free survival; Oncology; Ibrutinib; Chemotherapy; Leukemia; Adverse effect; Lymphoma","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002843588,0.001173746,0.001886476,0.0005628191,0.0004651226,0.001070298,0.0008131403,0.001029306,0.003082269],"category_scores_gemma":[0.001641263,0.0002999991,0.002471733,0.0005416679,0.0006310467,0.001566431,0.0006765208,0.002918987,0.0007696868],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00113418,"about_ca_system_score_gemma":0.0009797688,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009137836,"about_ca_topic_score_gemma":0.00160284,"domain_scores_codex":[0.9992222,0.0002831011,0.00005061531,0.0001370678,0.0001096159,0.0001974917],"domain_scores_gemma":[0.9984998,0.0002834144,0.0004564218,0.0001261429,0.00009036362,0.0005439473],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9035419,0.01253768,0.01440838,0.0002874061,0.001736671,0.0001372216,0.00009250267,0.001903736,0.003523991,0.00008251308,0.002850278,0.0588978],"study_design_scores_gemma":[0.253444,0.6191866,0.1082818,0.0001347672,0.004059906,0.0005328709,0.0001648297,0.004524994,0.003977486,0.0005962583,0.005010157,0.00008622187],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9935962,0.002784308,0.0001896862,0.0002991087,0.0001141349,0.0002803014,0.001444584,0.00006608193,0.001225399],"genre_scores_gemma":[0.9929924,0.0009782254,0.0003724934,0.0004552278,0.00022077,0.0003402331,0.003403281,0.00001599925,0.001221326],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003082269,"threshold_uncertainty_score":0.01503849,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03080507309312887,"score_gpt":0.3009799521374058,"score_spread":0.2701748790442769,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}